News About: Pharm. Industry
Kim Han-sang named to head Mundipharma Malaysia divisionStarting in August, Mundipharma Korea managing director Kim Han-sang will be tasked to lead Mundipharma’s Malaysia division, company officials said Thursday.
Kim will become ...
|
Delayed passage of anti-rebate bill gets mixed reactions
As the National Assembly’s Health and Welfare Committee on Wednesday decided not to push for legislation that will implement tougher anti-violence measures against drug makers during this month’s parliamentary session...
Samjin’s anti-dementia drug targeting sales of 10 billion won this yearSamjin Pharmaceutical said Thursday that the sales of its anti-dementia drug Neutoin (donepezil) will reach 10 billion won this year on growing demand due to the growing number ...
|
CJ gets approval for incrementally modified drug Vogmet
CJ Cheil Jedang has received approval for its incrementally modified drug Vogmet for the treatment of diabetes.
CJ said on Wednesday that the Ministry of Food and Drug Safety (MFDS) had given the green light to Vog...
Leading drug makers hits by sluggish outpatient sales in May
Domestic and foreign drug companies witnessed their outpatient sales fall in May from a year earlier, data showed Tuesday.
Korea’s outpatient sales came to 773.3 billion won last month, down 2.6 percent compared to...
Japanese companies hold kick-off meeting
The special committee for Japanese drug firms in Korea, under the umbrella of the Korea Pharmaceutical Manufacturers Association (KPMA), had its first meeting at Palace Hotel in Seoul on Tuesday.
Last December, eig...
Whanin Pharm to distribute Novartis’s Clozaril
Whanin Pharmaceutical said Tuesday that it had signed a distribution agreement with Novartis Korea for the exclusive sale of the latter’s Clozaril (clozapine) here, starting in July 1.
Clozapine is an atypical anti...
Korea ranks 7th in global pharmaceutical patent filings
Korea ranked seventh and eighth last year in the number of international patent applications related to pharmaceutical and medical device sectors, with Osstem Implant leading the way.
The nation filed for 825 inter...
Ildong Pharm hike Bayer’s OTC drugs by up to 10%
Ildong Pharmaceutical has recently jacked up the retail prices of over-the-counter (OTC) products transferred by Bayer Korea by 5 to 10 percent.
According to the company, Canesten (clotrimazole) rose by five percen...
Celltrion CEO’s stake sell-off plan yet to be finalized
Celltrion said Monday that the company has yet to finalize its plan to sell the entire controlling stake of Celltrion Chairman and CEO Seo Jung-jin to a multinational pharmaceutical company.
In a regulatory filing ...
